In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1661 News Items found
person donating blood
COVID-19 Has Caused a National Blood Shortage. People with Cancer Need Your Help.

Find out how you can help Memorial Sloan Kettering through the national blood shortage.
In the Lab
Physician-scientist Omar Abdel-Wahab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
Ben, Kyle, Charles, and Gloria on a picnic blanket
Meet Ben Hegel, A Proud and Fierce Family Man

Meet Ben Hegel, a senior program coordinator in the Sloan Kettering Institute. “My introduction to Pride in college was through a celebratory lens,” says Ben. “But my relationship to Pride has changed.” He still celebrates, but he points out that the Pride March is just that — a march, not a parade. “It was started by marginalized people who were marching for their rights.”
MSK computational biologist Sohrab Shah
Scientists Obtain Real-Time Look at How Cancers Evolve

With the help of machine learning, computational biologists are learning to predict how cancers will evolve.
Yasmin Khakoo
Finding an Unexpected Calling: 8 Questions with Child Neurologist Yasmin Khakoo

Yasmin Khakoo is a pediatric neurologist and neuro-oncologist who directs the Child Neurology Program at MSK Kids.
Finding
Zsofia Stadler
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
SKI immunologist Michael Glickman
MSK Scientists Solve One of TB’s Deadliest Tricks

Scientists at Memorial Sloan Kettering have pieced together the biochemical mechanism by which the tuberculosis bacterium sneaks past our immune defenses.
Feature
marijuana joint
Now that Weed Is Becoming Legalized, Should More People with Cancer Use Cannabis?

Find out what Memorial Sloan Kettering experts recommend when it comes to marijuana, CBD, and other forms of cannabis for cancer.
In the Lab
Developmental biologist Luis Parada
Stem Cells May Explain Why Rare Inherited Tumor in Kids Is So Aggressive

Sloan Kettering Institute investigators have found that a subpopulation of cells within a type of sarcoma called malignant peripheral nerve sheath tumor appear to be similar to a type of neural stem cells.
msk patient christopher jeter and his wife connie
You’ve Finished Cancer Treatment. Now What? MSK’s Survivorship Program Provides Expert Care

Meet Christopher Jeter, who was diagnosed nearly 10 years ago with lung cancer. He was successfully treated at Memorial Sloan Kettering and now is being closely monitored by experts in MSK's Adult Survivorship Program.